Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$688M Buy
6,431,196
+63,313
+1% +$6.96M 0.16% 105
2026
Q1
$669M Buy
6,367,883
+36,385
+0.6% +$4.27M 0.18% 105
2025
Q4
$790M Buy
6,331,498
+10,781
+0.2% +$1.28M 0.21% 87
2025
Q3
$758M Buy
6,320,717
+126,285
+2% +$13.3M 0.2% 90
2025
Q2
$569M Sell
6,194,432
-602,065
-9% -$54.9M 0.16% 123
2025
Q1
$598M Buy
6,796,497
+163,413
+2% +$16.1M 0.18% 107
2024
Q4
$614M Sell
6,633,084
-86,204
-1% -$8.3M 0.17% 100
2024
Q3
$623M Buy
6,719,288
+239,999
+4% +$20.2M 0.17% 108
2024
Q2
$486M Sell
6,479,289
-824,661
-11% -$65.8M 0.14% 124
2024
Q1
$630M Sell
7,303,950
-685,947
-9% -$52.4M 0.19% 108
2023
Q4
$552M Buy
+7,989,897
New +$482M 0.18% 110
2015
Q1
Sell
-112,089
Closed -$2.69M 1599
2014
Q4
$2.69M Buy
+112,089
New +$2.54M 0.02% 734

Other funds holding CRH

Nuveen's CRH Position: Q2 2026 in Review

Nuveen increased its CRH (CRH) stake by 0.99% in Q2 2026, buying an estimated $6.96M and bringing the position to 6,431,196 shares worth $688M. The position accounts for 0.16% of the portfolio, ranked #105.

Nuveen first reported a position in CRH in Q4 2014 and has held it in 12 quarters since. The position peaked at $790M in Q4 2025. 1,025 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Nuveen held 6,431,196 shares of CRH worth $688M as of Q2 2026.
  • Nuveen bought 63,313 CRH shares in Q2 2026, an estimated $6.96M.
  • CRH made up 0.16% of Nuveen's portfolio in Q2 2026, its #105 holding.
  • Nuveen first reported a position in CRH in Q4 2014 and has held it in 12 quarters since.
  • Nuveen's CRH position peaked at $790M in Q4 2025.
  • 1,025 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.